These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17900571)

  • 41. Binding to PCNA in Euryarchaeal DNA Replication requires two PIP motifs for DNA polymerase D and one PIP motif for DNA polymerase B.
    Castrec B; Rouillon C; Henneke G; Flament D; Querellou J; Raffin JP
    J Mol Biol; 2009 Nov; 394(2):209-18. PubMed ID: 19781553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of nuclear protein complexes comprising alpha-actinin-4 by 2D-electrophoresis and mass-spectrometry].
    Khotin MG; Turoverova LV; Podol'skaia EP; Krasnov IA; Solov'eva AV; Aksenova VIu; Magnusson KE; Pinaev GP; Tentler DG
    Tsitologiia; 2009; 51(8):684-90. PubMed ID: 19799353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.
    Shemesh A; Kundu K; Peleg R; Yossef R; Kaplanov I; Ghosh S; Khrapunsky Y; Gershoni-Yahalom O; Rabinski T; Cerwenka A; Atlas R; Porgador A
    Front Immunol; 2018; 9():1114. PubMed ID: 29875773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation.
    Cardano M; Tribioli C; Prosperi E
    Curr Cancer Drug Targets; 2020; 20(4):240-252. PubMed ID: 31951183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human C6orf211 encodes Armt1, a protein carboxyl methyltransferase that targets PCNA and is linked to the DNA damage response.
    Perry JJ; Ballard GD; Albert AE; Dobrolecki LE; Malkas LH; Hoelz DJ
    Cell Rep; 2015 Mar; 10(8):1288-96. PubMed ID: 25732820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression patterns of proliferating cell nuclear antigen in trichloroacetic acid peeled skin.
    Yamamoto Y; Uede K; Yonei N; Furukawa F
    J Dermatol; 2007 Feb; 34(2):95-8. PubMed ID: 17239145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear protein isoforms: implications for cancer diagnosis and therapy.
    Shen F; Kirmani KZ; Xiao Z; Thirlby BH; Hickey RJ; Malkas LH
    J Cell Biochem; 2011 Mar; 112(3):756-60. PubMed ID: 21328449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of thymus PCNA expression is altered in radiation-sensitive wasted mice.
    Woloschak GE; Paunesku T; Libertin CR; Chang-Liu CM; Churchill M; Panozzo J; Grdina D; Gemmell MA; Giometti C
    Carcinogenesis; 1996 Nov; 17(11):2357-65. PubMed ID: 8968049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the nuclear distribution of cyclin (PCNA) during S-phase are not triggered by post-translational modifications that are expected to moderately affect its charge.
    Bravo R; Celis JE
    FEBS Lett; 1985 Mar; 182(2):435-40. PubMed ID: 2858409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Embryonic PCNA: a missing link?
    Kelman Z; O'Donnell M
    Curr Biol; 1995 Jul; 5(7):814. PubMed ID: 7583129
    [No Abstract]   [Full Text] [Related]  

  • 51. [What is a cancer cell?].
    Paul J
    Quintessenz; 1975 Apr; 26(4):127-31. PubMed ID: 1061200
    [No Abstract]   [Full Text] [Related]  

  • 52. Microvilli: a major difference between normal and cancer cells?
    Kolata GB
    Science; 1975 May; 188(4190):819-20. PubMed ID: 17769885
    [No Abstract]   [Full Text] [Related]  

  • 53. [Nuclear individuality of cancer cells].
    WAINRACH S
    Rev Clin Esp; 1963 Jan; 88():97-108. PubMed ID: 13998323
    [No Abstract]   [Full Text] [Related]  

  • 54. PCNA News.
    J Cardiovasc Nurs; 2019; 34(5):353-356. PubMed ID: 31403501
    [No Abstract]   [Full Text] [Related]  

  • 55. PCNA on the crossroad of cancer.
    Stoimenov I; Helleday T
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):605-13. PubMed ID: 19442257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.
    Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH
    Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A unique form of proliferating cell nuclear antigen is present in malignant breast cells.
    Bechtel PE; Hickey RJ; Schnaper L; Sekowski JW; Long BJ; Freund R; Liu N; Rodriguez-Valenzuela C; Malkas LH
    Cancer Res; 1998 Aug; 58(15):3264-9. PubMed ID: 9699653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A FRET-Based Assay for the Identification of PCNA Inhibitors.
    Hardebeck S; Schreiber S; Adick A; Langer K; Jose J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic Targeting of DNA Replication Stress in Cancer.
    Gu L; Hickey RJ; Malkas LH
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A PCNA-derived cell permeable peptide selectively inhibits neuroblastoma cell growth.
    Gu L; Smith S; Li C; Hickey RJ; Stark JM; Fields GB; Lang WH; Sandoval JA; Malkas LH
    PLoS One; 2014; 9(4):e94773. PubMed ID: 24728180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.